Skip to content
Riskpilot
← Back to search
Sign in
Get full access
TAKE-Life Science & Business Partner AB
AB
Active
Org 5568854052
Rabeniusvägen 5 A, 756 55
Uppsala
Business and other management consultancy activities
· NACE 7020
Est. 2012
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
TAKE-Life Science & Business Partner AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
413
213
679
130
121
Staff expenses
—
−13
−25
−14
−4
EBITDA
318
102
514
−10
44
Depreciation & amort.
−0
—
—
—
—
EBIT
318
102
514
−10
44
Net financials
8
−0
−1
−2
−3
Profit before tax
309
102
513
−12
40
Tax
−16
−24
−112
−4
−12
Net profit
293
78
401
−16
28
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
628
252
757
273
225
Equity
535
163
464
148
176
Long-term debt
0
—
—
—
—
Short-term debt
93
89
292
125
48
Total debt
93
89
292
125
48
Financial ratios
5-year trend
EBITDA margin
36.0%
This company
15.8%
Market median
+128% vs market
2021
2025
Equity ratio
78.4%
This company
38.2%
Market median
+105% vs market
2021
2025
Return on equity
16.1%
This company
18.4%
Market median
+12% vs market
2021
2025
Net profit margin
23.3%
This company
8.1%
Market median
+188% vs market
2021
2025
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on TAKE-Life Science & Business Partner AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
